PATH | VRL
Menu

Find resources

Total results with these characteristics: 194

Topic: Immunization financing

Page 3 of 10
Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso

Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond …

Author: Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A

Publication date: 2011

Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL Study

Investigators found that rotavirus gastroenteritis incurs considerable use of health care resources and results in substantial costs for families of patients and employers. Routine rotavirus vaccination could significantly reduce the related …

Author: Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M

Publication date: 2007

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries

This article, published in PLoS ONE, describes the data and analysis shared with GAVI Alliance policymakers regarding their support of human papillomavirus (HPV) vaccine. The authors review why strategies and costs for HPV vaccine delivery are …

Author: Levin A, Wang SA, Levin C, Tsu V, Hutubessy R

Publication date: 2014

Country Ownership and Gavi Transition: Comprehensive Approaches to Supporting New Vaccine Introduction

This article, published in Health Affairs, outlines countries' increasing emphasis on cost-effectiveness analysis, program costing, and financial flows—particularly for the introduction of newer, more expensive vaccines. While this is critical to …

Author: Shen AK, Weiss JM, Andrus JK, et al.

Publication date: 2016

Country Specific Predictions of the Cost-Effectiveness of Malaria Vaccine RTS,S/AS01 in Endemic Africa

This article, published in Vaccine, examines the cost-effectiveness and impact of malaria vaccine candidate RTS,S/AS01 in Africa. Using a variety of models of Plasmodium falciparum epidemiology, the study found that if RTS,S was implemented in 43 …

Author: Galactionova K, Tediosi F, Camponovo F, Smith TA, Gething PW, Penny MA

Publication date: 2017

Country Tools for Typhoid Prevention and Control

This web page provides country-specific resources that outline the health and economic burden of typhoid as well as potential benefits of new typhoid conjugate vaccines (TCVs) for each country. They also highlight the 2018 recommendation from the …

Author: Take on Typhoid

Current Global Pricing for Human Papillomavirus Vaccines Brings the Greatest Economic Benefits to Rich Countries

This article, published in Health Affairs, details an economic model that estimates the distribution of the economic surplus—the sum of all health and economic benefits of a vaccine, minus the costs of development, production, and …

Author: Herlihy N, Hutubessy R, Jit M

Publication date: 2016

A Decade of Sustainable Immunization Financing

This report documents a decade of work through the Sustainable Immunization Financing (SIF) Program to help countries work toward independent solutions for funding their immunization programs. It explains the importance of sustainable domestic …

Author: Sabin Vaccine Institute

Publication date: 2019

Decade of Vaccines

This supplement to Vaccine features articles on the Decade of Vaccines Global Vaccine Action Plan strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles in the supplement cover a range of …

Author: Alonso PL, de Quadros CA, Lal AA, eds.

Publication date: 2013

Delivering the Money: The Importance of Efficient Financial Flows for Vaccine Distribution

This policy paper explores the impact of adequate and reliable flows of funding all the way to the point of care as a critical component of effective immunization supply chains. It illuminates the root causes of funding flow challenges and …

Author: VillageReach, William Davidson Institute

Publication date: 2016

Delivering Vaccines: A Cost Comparison of In-Country Vaccine Transport Container Options

Project Optimize undertook a cost-comparison case study of five container options for vaccine transport from the national to the regional level in Senegal. This report may be used as a starting point for other country vaccine programs weighing …

Author: PATH, World Health Organization

Publication date: 2013

Delivery Cost of Human Papillomavirus Vaccination of Young Adolescent Girls in Peru, Uganda and Viet Nam

This article, published in the Bulletin of the World Health Organization, aimed to estimate the incremental delivery cost of human papillomavirus (HPV) vaccination of young adolescent girls in three countries. They found that the delivery cost per …

Author: Levin CE, Minh HV, Odaga J, et al.

Publication date: 2013

Disease Control Priorities in Developing Countries, Second Edition

A comprehensive global health examination, this book contributes substantially to global initiatives to improve the health of all peoples by providing a multidisciplinary understanding of fundamental issues and challenges, as well as effective …

Author: Disease Control Priorities Project

Publication date: 2008

Distributional Impact of Rotavirus Vaccination in 25 GAVI Countries: Estimating Disparities in Benefits and Cost-Effectiveness

This article, published in Vaccine, reports on an analysis that combines the results of a country-level model of rotavirus vaccination published elsewhere with data from Demographic and Health Surveys on within-country patterns of vaccine coverage …

Author: Rheingans R, Atherly D, Anderson J

Publication date: 2012

The Economic Burden Attributable to a Child’s Inpatient Admission for Diarrheal Disease in Rwanda

This article, published in PLoS ONE, reports the results of a study that aimed to estimate the economic burden attributable to hospitalization for diarrhea among children less than five years old in Rwanda. The authors also compared the economic …

Author: Ngabo F, Mvundura M, Gazley L, et al.

Publication date: 2016

The Economic Burden of Childhood Pneumococcal Diseases in The Gambia

This article, published in Cost Effectiveness and Resource Allocation, presents the results of a study that aimed to estimate, from a societal perspective, the costs incurred by health providers and families of children with pneumococcal diseases in …

Author: Usuf E, Mackenzie G, Sambou S, Atherly D, Suraratdecha C

Publication date: 2016

Economic Costs of Rotavirus Gastroenteritis and Cost-Effectiveness of Vaccination in Developing Countries

This article, published in The Journal of Infectious Diseases, evaluated the economic burden of rotavirus and the cost-effectiveness of vaccination from the health care perspective. The authors found that rotavirus vaccination would annually prevent …

Author: Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD

Publication date: 2009

An Economic Evaluation of the Controlled Temperature Chain Approach for Vaccine Logistics: Evidence From a Study Conducted During a Meningitis A Vaccine Campaign in Togo

This article, published in The Pan African Medical Journal, reports the results of a costing study conducted in Togo’s Central Region during a 2014 MenAfriVac® vaccine introduction campaign. The study evaluated the economic benefits of using an …

Author: Mvundura M, Lydon P, Gueye A, et al.

Publication date: 2017

Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009

This article, published in Pediatrics, presents an economic analysis of the US childhood immunization schedule. The study used population-based vaccination coverage, vaccine efficacy data, historical data on disease incidence before vaccination, and …

Author: Zhou F, Shefer A, Wenger J, et al.

Publication date: 2014

An Economic Evaluation of Thermostable Vaccines in Cambodia, Ghana, and Bangladesh

This article, published in Vaccine, evaluates the incremental health and programmatic cost impacts of theoretical new vaccine products as compared to the standard vaccine products in multi-dose vials in Cambodia, Ghana, and Bangladesh. The authors …

Author: Levin A, Levin C, Kristensen D, Matthias D

Publication date: 2007

Page 3 of 10